期刊文献+

两组药物治疗解脲脲原体感染的疗效观察 被引量:4

Observation on Clinical Efficacy of Two Groups of Medicine in the Treatment of the Ureaplasma Urealyticum Infection
下载PDF
导出
摘要 目的探讨治疗解脲脲原体感染,防止复发的有效方法。方法560例解脲脲原体培养阳性患者随机分为两组。A组给予济尼新、乳酸氟罗沙星口服,B组给予舒美特、司帕沙星口服,均疗程2周,并随访1个月。结果A组有效率为95%,B组为61%,复发率A组为10%,B组为35%。结论济尼新、乳酸氟罗沙星口服,疗程14天,是治疗解脲脲原体感染较好的方法之一。 Objective To assess the effective and best method to treat and prevent of the Ureaplasma urealyticum infection.Methods 560 cases were divided into 2 groups.Group A was administrated Thiamphenicol and Fleroxacin through oral way in 14 days.Group B was administrated Azithromycin and Sparfloxacin through oral way in 14 days.Follow up all patients in 1 month.Results The cured rate of Group A was 95%;the cured rate of group B was 61%.The relapse rate of Group A was 10%;the relapse rate of Group B was 35%.Conclusion To administrated Thiamphenicol and Fleroxacin through oral way in a therapy period lasting for 14 days is one of the best method to treat the infection of Ureaplasma urealyticum.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2005年第5期292-293,共2页 The Chinese Journal of Dermatovenereology
关键词 解脲脲原体感染 临床疗效 Ureaplasma urealyticum infection Clinical efficacy
  • 相关文献

参考文献3

二级参考文献5

共引文献63

同被引文献12

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部